Arjen H.G. Cleven - Concepedia

Author

Arjen H.G. Cleven

Also Known As

A H G Cleven, A. Cleven, A. H. G. Cleven, A.H. Cleven∗, A.H. G. Cleven, A.H.G. Cleven, Arjen Cleven, Arjen H Cleven, Arjen H G Cleven, Arjen H. Cleven

122

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center University Medical Center Groningen Amsterdam University Medical Centers Maastricht University Leiden University

About

Arjen H.G. Cleven is an author at Leiden University Medical Center specializing in medicine, pathology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1.1K
2	Health Sciences	2	2	67
3	Engineering	1	1	51
4	Natural Sciences	1	1	39
5	Biology	1	1	25

Arjen H.G. Cleven

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival Arjen H.G. Cleven, Ghadah Al Sannaa, Inge H. Briaire‐de Bruijn, Modern Pathology Tumoral PathologyTumor InnervationMedicineSurgical PathologyPathology	2016	235
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma Arjen H.G. Cleven, Saskia Höcker, Inge H. Briaire‐de Bruijn, The American Journal of Surgical Pathology Tumor BiologyDiagnostic ToolAtrx ExpressionH3k36 TrimethylationTumoral Pathology	2015	198
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation François Le Loarer, Arjen H.G. Cleven, Corinne Bouvier, Modern Pathology Tumor BiologySpindle Cell RhabdomyosarcomasTfcp2 FusionsOncogenic AgentCommon Alk Upregulation	2019	130
Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR–Based Targeted Next-Generation Sequencing Suk Wai Lam, Anne‐Marie Cleton-Jansen, Arjen H.G. Cleven, Journal of Molecular Diagnostics MedicinePathologyCancer GenomicsMolecular PathologyGene Fusions	2018	112
Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype Marie Kostine, Arjen H.G. Cleven, Noel F.C.C. de Miranda, Modern Pathology HistocompatibilityAutoimmune DiseaseImmunologyPathologyDedifferentiated Subtype	2016	107
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy Yayan T. Sundara, Marie Kostine, Arjen H.G. Cleven, Cancer Immunology Immunotherapy	2016	103
<i>MYD88</i> mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis Joost S.P. Vermaat, Sebastiaan Somers, Liesbeth C. de Wreede, Haematologica	2019	88
Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma Suk Wai Lam, Arjen H.G. Cleven, Herman M. Kroon, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin	2019	67
IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas Arjen H.G. Cleven, Johnny Suijker, Georgios Agrogiannis, Clinical Sarcoma Research	2017	65
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation Elisabeth F.P. Peterse, Bertine Niessen, Ruben D. Addie, British Journal of Cancer	2018	58

Page 1